ALLK | Allakos Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.7962 - 0.9290
52 Week Range	0.5400 - 3.41
Beta	0.47
Implied Volatility	336.77%
IV Rank	45.92%
Day's Volume	569,850
Average Volume	683,956
Shares Outstanding	89,343,600
Market Cap	78,318,600
Sector	Healthcare
Industry	Biotechnology
IPO Date	2018-07-19

Valuation
Profitability
Growth
Health
P/E Ratio	-0.43
Forward P/E Ratio	N/A
EPS	-2.03
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	131
Country	USA
Website	ALLK

Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and/or eosinophilic duodenitis; a Phase II/III study for eosinophilic esophagitis; and a Phase II clinical study to atopic dermatitis and chronic spontaneous urticaria. It is also developing lirentelimab (AK002) for the treatment of mast cell gastrointestinal disease, chronic urticaria, severe allergic conjunctivitis, and indolent systemic mastocytosis; and AK006 to treat allergic and inflammatory diseases. The company was incorporated in 2012 and is headquartered in Redwood City, California.

ALLK's peers: APLS, BPMC, KRTX, MRTX, DAWN, ATRA, FATE, SANA, CRBU, RCUS, RARE, CRNX, ARVN, RVMD, KURA, NXTC, CTMX, NLTX, SPRO, ASMB, ALLO, GTHX, HRTX, ANNX, SGMO

*Chart delayed

Analyzing fundamentals for ALLK we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is very weak. For more detailed analysis please see ALLK Fundamentals page.

Watching at ALLK technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on ALLK Technicals page.